Wellington Management Group LLP reduced its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 10.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,388,762 shares of the company's stock after selling 1,936,361 shares during the quarter. Wellington Management Group LLP owned approximately 10.01% of Option Care Health worth $572,787,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Brooklyn Investment Group grew its position in Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after acquiring an additional 780 shares in the last quarter. Bessemer Group Inc. grew its position in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after acquiring an additional 599 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares in the last quarter. Wealthquest Corp acquired a new position in Option Care Health in the 1st quarter valued at about $66,000. Finally, Farther Finance Advisors LLC grew its position in Option Care Health by 434.8% in the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock valued at $67,000 after acquiring an additional 1,561 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on OPCH shares. JMP Securities lifted their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.75.
View Our Latest Stock Report on Option Care Health
Option Care Health Price Performance
OPCH stock opened at $28.19 on Tuesday. The business has a 50 day moving average price of $30.22 and a 200 day moving average price of $31.84. The stock has a market cap of $4.57 billion, a price-to-earnings ratio of 22.55, a PEG ratio of 1.79 and a beta of 0.79. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm's revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.30 earnings per share. Equities research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.